Clinical Trial: A Study of HS-20136-2 in Healthy Participants

U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07483437) titled 'A Study of HS-20136-2 in Healthy Participants' on March 12.

Brief Summary: This is a randomized, double-blind,placebo-controlled phase I clinical study.The main purpose is to assess the safety and tolerability of single subcutaneous administration of HS-20136-2 injection in healthy participants.

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: HS-20136-2 injection

Administrated SC

DRUG: HS-20136-2 injection Placebo

Administrated SC

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.

Disclaimer: Curated by HT Syndication....